Colgate India Q2 Review - Performance Fails To Impress: Systematix
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Systematix Research Report
Colgate-Palmolive India Ltd.’s Q2 FY22 results were below consensus and our estimates.
Revenue grew 5.2% YoY on a low base, resulting in a two-year revenue compound annual growth rate of 5.3% (a sequential improvement from 3.7% in Q1 FY22).
We estimate toothpaste volume growth of ~2% YoY in Q2 FY22 (on a base of 3% YoY).
Ebitda margin was 29.6% versus our estimate of 30% due to gross margin contraction of 130 basis points YoY and higher advertisement and promotion spend (up 90 bps YoY to 13.7% of sales).
Ebitda/adjusted profit after tax declined 2.1%/1.8% YoY, respectively.
Colgate India’s strategy of driving brand penetration through marketing spend, focus on new product innovation and strengthening go-to-market across e-commerce, modern trade and wholesale channels are efforts in the right direction.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.